Browsing by Author Briscoe, Karen

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 6 of 6
Issue DateTitleAuthor(s)Citation
2010Adjuvant chemotherapy for early colon cancer: What survival benefits make it worthwhile?Beale, Philip; Blinman, Prunella; Clarke, Stephen; Duric, Vlatka; Hudson, Malcolm; Stockler, Martin; Boyce, Adam; Briscoe, Karen; Goldstein, David; Nowak, Anna K.; Central Clinical School: Medicine; School of Public Health: Public Health; Northern Clinical School: Kolling Institute; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreAdjuvant chemotherapy for early colon cancer: What survival benefits make it worthwhile?, European Journal of Cancer, vol.46, 10, 2010,pp 1800-1807
2017A distinct plasma lipid signature associated with poor prognosis in castration-resistant prostate cancerGurney, Howard; Horvath, Lisa; Hoy, Andrew; Marx, Gavin; Stockler, Martin; Briscoe, Karen; Daly, Roger; Lin, Hui-Ming; Mahon, Kate; Mallesara, Girish; Meikle, Peter; Mundra, Piyushkumar; Parton, Robert G.; Spielman, Calan; Weir, Jacquelyn; Western Clinical School: Medicine (Westmead); Central Clinical School: Medicine; School of Medical Sciences: Physiology; SAHCS: Medicine; NH&MRC Clinical Trials CentreA distinct plasma lipid signature associated with poor prognosis in castration-resistant prostate cancer, International Journal of Cancer, vol.141, 10, 2017,pp 2112-2120
2017Phase 2 study of circulating microRNA biomarkers in castration-resistant prostate cancerHorvath, Lisa; Marx, Gavin; Stockler, Martin; Bastick, Patricia; Briscoe, Karen; Gurney, H; Lin, H; Mahon, Kate; Mallesara, Girish; Spielman, Calan; Swarbrick, A; Central Clinical School: Medicine; SAHCS: Medicine; NH&MRC Clinical Trials CentrePhase 2 study of circulating microRNA biomarkers in castration-resistant prostate cancer, British Journal of Cancer, vol.116, 8, 2017,pp 1002-1011
2015A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australasian lung cancer trials group NITRO trialBoyer, Michael; Chan, Matthew; Chinchen, Sarah; Coskinas, Xanthi; Espinoza, David; Pavlakis, Nick; Stockler, Martin; Tognela, Annette; Veillard, Anne-Sophie; Abdi, E; Begbie, S; Boyce, Adam; Briscoe, Karen; Crombie, C.; Davidson, A; et al, Various; Huighes, B G M; Lewis, C R; Long, J; Varma, S; Central Clinical School: Medicine; Northern Clinical School: Melanoma Institute of Australia; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreA phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australasian lung cancer trials group NITRO trial, Annals of Oncology, vol.26, 11, 2015,pp 2280-2286
2016Toxic Epidermal Necrolysis-like Reaction With Severe Satellite Cell Necrosis Associated With Nivolumab in a Patient With Ipilimumab Refractory Metastatic MelanomaFernandez Penas, Pablo; Briscoe, Karen; Nayar, Namrata; Western Clinical School: Medicine (Westmead)Toxic Epidermal Necrolysis-like Reaction With Severe Satellite Cell Necrosis Associated With Nivolumab in a Patient With Ipilimumab Refractory Metastatic Melanoma, Journal of Immunotherapy, vol.39, 3, 2016,pp 149-152
2016Toxic Epidermal Necrolysis-like Reaction With Severe Satellite Cell Necrosis Associated With Nivolumab in a Patient With Ipilimumab Refractory Metastatic MelanomaFernandez Penas, Pablo; Briscoe, Karen; Nayar, Namrata; Western Clinical School: Medicine (Westmead)Toxic Epidermal Necrolysis-like Reaction With Severe Satellite Cell Necrosis Associated With Nivolumab in a Patient With Ipilimumab Refractory Metastatic Melanoma, Journal of Immunotherapy, vol.39, 3, 2016,pp 149-152